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Abstrak 
 
Pengetahuan tentang profil farmakologi fentanyl dan efek sampingnya 
merupakan bahasan penting untuk penatalaksanaan pada kontrol nyeri. 
Sehingga pada penelitian ini didesain untuk meneliti keuntungan pengobatan 
dengan fentanyl dan efek sampingnya seperti muntah dan konstipasi. Hasil 
penelitian menunjukkan bahwa fentanyl menghasilkan efek analgesik yang 
lebih kuat dibandingkan dengan morfin pada mencit dan ferret. Hasil 
penemuan ini sesuai dengan penggunaan fentanyl di klinik. Morfin dengan 
dosis yang lebih rendah dibandingkan dengan dosis analgesik secara 
signifikan menghambat gastrointestinal transit sedangkan fentanyl tidak 
menimbulkan efek samping serupa. Pada studi klinik pada pasien nyeri 
kronik kanker menunjukkan bahwa sediaan transdermal fentanyl (TTS-
fentanyl) mempunyai efek samping yang kecil pada penghambatan 
gastrointestinal transit, mual dan muntah dibandingkan dengan oral morfin. 
Pada dosis kecil dibandingkan dosis analgesik morfin juga menimbulkan efek 
samping mual dan muntah, sedangkan fentanyl tidak menimbulkan efek 
samping serupa pada ferret. Hasil penemuan ini mengindikasikan bahwa 
fentanyl menimbulkan efek samping mual dan muntah yang lebih kecil 
dibandingkan dengan morfin. Secara keseluruhan dapat disimpulkan bahwa 
fentanyl menghasilkan efek analgesik yang kuat pada mencit dan ferret. 
Disamping itu fentanyl menimbulkan efek samping muntah dan konstipasi 
yang kecil dibandingkan morfin. Hasil penemuan ini dapat digunakan dan 
mungkin bermanfaat terhadap penggunaan fentanyl pada klinik untuk 
penatalaksanaan pengobatan nyeri kronik.  
Kata kunci: fentanyl, analgesik, muntah, ferret 
 
Abstract 
 
The understanding of the pharmacological profiles of fentanyl and 
fentanyl-related side effects seems to be critical for the management for 
control of pain. Therefore, the present study was designed to investigate the 
advantages for treatment with fentanyl and the side effects such as emesis 
and gastrointestinal transit inhibition. The results demonstrated that fentanyl 
produced a profound antinociception in ferrets and mice than that induced by 
morphine. These findings are consistent with the experiences in the clinic. 
Morphine with lower doses than antinociceptive doses, produced a significant 
increase in gastrointestinal transit inhibition. However, fentanyl produced no 
gastrointestinal transit inhibition unlike morphine. These findings are 
consistent with the clinical experiences in the use of fentanyl. The clinical 
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studies in patients chronic cancer pain showed that transdermal therapeutic 
delivery system for fentanyl (TTS-fentanyl) produces less side effects such as 
constipation, nausea and vomiting than that induced by oral morphine. 
Morphine with lower doses than that used for antinociceptive assay also 
produced either in the number of retching or vomiting. However, fentanyl 
failed to produce emetic response in ferrets. These findings indicate that 
fentanyl produces much less emesis than that induced by morphine. Finally, 
we conclude that fentanyl produced potent antinociception in ferrets and 
mice. In addition, fentanyl produced much less side effects including emesis 
and constipation. These findings may provide evidence for benefit and 
usefulness of fentanyl for clinical frame on the management of pain 
treatment. 
Key word: fentanyl; antinociception; emesis; ferret. 
 
Introduction 
Morphine has long been “gold standard” 
for the treatment of  moderate to severe cancer 
pain. However, morphine possesses several side 
effects such as emesis, constipation and drow-
siness, which have provoked the use of  “opioid 
rotation” to alternative opioids. Fentanyl, which 
is a one series of  potent opioids synthetic 
analgesic, has a high affinity for µ-opioid recep-
tor and exhibits 50-100 times more potent 
analgesic activity than that of  morphine. In the 
clinic, fentanyl is mainly used as epidural 
anesthetic and it has been used for the opioid 
rotation. It is likely that reason for this limited 
clinical application is related to a poor under-
standing the functional mechanism of  fentanyl-
induced analgesic actions and fentanyl-related 
side effects. It should be noted and some 
studies in the preclinic and clinic reported that 
the side effects of  fentanyl are less than that of  
morphine (Ahmedzai and Brooks., 1997; Payne 
et al., 1998; Megens et al., 1998; Donner et al., 
1996). 
Opioid rotation is the practice of  
switching from one opioid to another, in order 
to improve an unfavorable balance of  analgesia 
and side effects. Opioids are generally the most 
effective treatment for patients with cancer 
pain, and pain can be effectively controlled in 
the most cancer patients with minimal toxicity 
until their last time. The rationale for opioid 
rotation is based on interindividual variability in 
response to different opioids, or intraindividual 
variability in response to the same opioid over 
time, which commonly appreciated clinical 
phenomena in the management of  pain 
(Tarumi, 2002). 
Successful pain management with 
opioids could be achieved by adequate analgesia 
without excessive side effects. Nausea and 
vomiting are common and troubling side 
effects of  opioid analgesic in the clinic 
(Aparasu et al., 1999). The incidence of  opioid-
induced nausea and vomiting is estimated to be 
10% to 40 %, and this symptom is ranked as 
highly distressing by patients (Urie et al., 2000). 
Opioids induce emesis through a number of  
mechanism: stimulation of  the chemoreceptor 
trigger zone (CTZ) in the brainstem or through 
enhanced vestibular sensitivity. Chronic dosing 
and gradual upward titration of  opioid dose 
may prevent the opioid-induced emesis. The 
opioid analgesics morphine is widely used to 
control pain in cancer patients. However, 
morphine induces severe constipation. It is 
estimated to occur in 25 % to 50 % of  cancer 
patients and is the most commonly occurring 
adverse effect of  chronic opioid therapy in 
patients with advanced cancer (Urie et al., 2000; 
Fallon and O’Neill., 1997; Fallon and Hanks., 
1999). Fentanyl is a potent analgesic and mainly 
used as epidural anesthetic. The clinical studies 
in chronic cancer pain showed provide 
evidence that transdermal therapeutic delivery 
system fentanyl (TTS-fentanyl) produces less 
side effects such as constipation, nausea and 
vomiting than that induced by oral morphine 
(Ahmedzai and Brooks., 1997; Donner and 
Zens., 1995; Donner et al., 1996). The basic 
investigations on the fentanyl-induced side 
effects such as emesis and constipation may 
help clinicians to get an alternative opioid with 
fewer side effects. 
The understanding of  the pharmaco-
logical profiles of  fentanyl and fentanyl-related 
side effects seems to be critical for the 
management for control of  pain. Therefore, 
the present study was then designed to 
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investigate the advantages for treatment with 
fentanyl and the side effects such as emesis and 
gastrointestinal transit inhibition.  
 
Methodology 
The present study was conducted in 
accordance with Guiding Principles for the Care and 
Use of  Laboratory Animals, Hoshi University, as 
adopted by the Committee on Animal Research of  
Hoshi University, which is accredited by the 
Ministry of  Education, Culture, Sports, Science and 
Technology of  Japan. Every effort was made to 
minimize the numbers and any suffering of  animal 
used in the following experiments.  
 
Animals 
Male ferrets weighing 1-1.5 kg were obtained 
from Marshall Research Labs (North Rose, NY, 
USA). Ferrets were individually housed in a room 
kept at 23±1oC under a 12 hr light/dark cycle (light 
on 08:00-20:00 hr). They were given a standard cat 
diet (70-80 g/animal, Oriental Co. Ltd., Chiba, 
Japan) and allowed free access water. Male ICR mice 
weighing 20-25 g and male Sprague-Dawley rats 
weighing 250-300 g were obtained from Tokyo 
Laboratory Animals Science Co., Ltd, Tokyo, Japan. 
The animals were housed in a room kept at 23±1oC 
under a 12 hr light/dark cycle (light on 08:00-20:00 
hr). Food and water were available ad libitum.  
 
Drugs 
The drugs used in the present study were 
morphine hydrochloride (Sankyo Co., Tokyo, Japan) 
and fentanyl citrate (Hisamitsu Co.Inc, Tokyo, 
Japan). 
 
Experimental procedures 
Antinociceptive assay (Randal-Selitto test) 
The antinociceptive effects induced by 
morphine or fentanyl were measured using Randall-
Selitto test analgesy-meter (Muromachi Kikai Co., 
Ltd., Tokyo, Japan). The pressure was directly 
applied to the tail of  the ferret via a negative-shape 
plunger. The tail withdrawal or vocalization was 
considered to be a nociceptive response. The 
pressure force was shown as grams and the cut-off  
force was set at 354 g. Ferrets were administered 
subcutaneously (s.c.) with morphine or fentanyl, and 
the measurement of  antinociception induced by 
these drugs were performed every 15 min after the 
injection. The antinociceptive effect was calculated 
as a percentage of  maximum possible effect (% 
antinociception) according to the following formula: 
% antinociception = (test threshold – predrug 
threshold) / (354 – predrug threshold) ×100. 
 
Antinociceptive assay (Tail-flick test) 
The antinociceptive response produced by 
fentanyl or morphine were evaluated by recording 
the tail-flick test (Tail Flick Analgesia Meter Model 
MK 300B, Muromachi Kikai Co. Ltd., Tokyo, 
Japan). To prevent tissue damage, we established a 
10 sec cut-off  time. The tail-flick latency was 
measured both before and after the challenge with 
fentanyl or morphine. Antinociceptive response was 
calculated as a percentage of  maximum possible 
effect (percentage of  antinociception) according the 
following  formula: % antinociception = (test 
latency – predrug latency)/(cut off  time – predrug 
latency) ×100. 
 
Evaluation of emetic response 
Before the measurement of  emesis induced 
by morphine or fentanyl, ferrets were acclimatized 
for 30 min in individual cages. The emetic response 
was evaluated by counting the number of  retching 
or vomiting for 30 min after the injections of  these 
drugs. Retching was defined as any rhythmic 
abdominal contraction without expulsion, whereas 
vomiting was defined as any oral expulsion (solid or 
liquid) from gastrointestinal tract. An assessment of  
emesis was made over a 30 min observation 
following the administration of  morphine or 
fentanyl. The onset time and duration time of  action 
of  the retching or vomiting following the drug 
injection were recorded for each animal. When 
ferrets did not show an emetic response, the latency 
was determined by the observation periods.  
 
Evaluation of gastrointestinal transit 
Gastrointestinal transit was measured 
according to the method of  Kamei et al (1995). Mice 
were fasted for 12-18 hr before the experiments. 
Twenty and five min after subcutaneous (s.c) 
injection of  morphine or fentanyl, the suspension 
of  charcoal was administered (p.o.) at the volume 
0.1 ml/mouse. Twenty min after charcoal adminis-
tration, the animal was killed by decapitation and its 
small intestine was removed. The small intestine 
placed on a ruled template and both the length from 
the pylorus to the cecum, and the distance traveled 
by the charcoal was measured. The percentage of  
gastrointestinal transit was calculated as: 100 
×(length from the pylorus to the cecum – distance 
traveled by the charcoal)/(length from the pylorus 
to the cecum). 
 
Statistical analysis 
The data are presented as the mean±S.E.M. 
The statistical significance of  differences between 
the groups was assessed with a two-way ANOVA, 
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Results and Discussion 
Antinociceptive effect of morphine or 
fentanyl following s.c. injection in the ferrets 
Randall-Selitto test 
In the present study, we confirmed that 
either morphine (1.5, 3 and 6 mg/kg, s.c.) or 
fentanyl (10, 30 and 56 µg/kg, s.c.) produced a 
dose-dependent antinociception in the ferret 
using Randall-Selitto test. The maximal 
antinociceptive response induced by morphine 
or fentanyl was reached at 30 min and 15 min 
after the injection, respectively (Fig.1). Ferret 
has been accepted and usually used as an 
animal model for the study of  nausea and 
vomiting (Rudd et al., 1994). However, in the 
present study using Randal-Selitto test, ferrets 
were also used for antinociceptive assay 
induced by opioids. The ED50 values for the 
antinociception induced by morphine or 
fentanyl were 2.84 (2.48-3.24) mg/kg and 31.67 
(26.74-37.42) µg/kg respectively (Fig.2). The 
ED50 value of  antinociception induced by 
fentanyl was approximately 90 times lower than 
ED50 value of  antinociception induced by 
morphine (Fig.2). The results demonstrated 
that fentanyl produced a profound antinocicep-
tion in ferrets than that induced by morphine. 
 
Antinociceptive effect and gastrointestinal 
transit inhibition induced by morphine or 
fentanyl following s.c. injection in mice 
Morphine (1, 1.7, 3 and 5.6 mg/kg, s.c.) 
or fentanyl (10, 17, 30 and 56 µg/kg, s.c.) 
produced a dose-dependent antinociception in 
the mouse-tail flick test. The maximal antinoci-
ceptive responses induced by morphine or 
fentanyl was reached at 30 min and 15 min after 
the injection, respectively. The ED50 values for 
the antinociception induced by morphine or 
fentanyl were 2.12 (1.31-3.28) mg/kg and 25.31 
(12.76-47.29) µg/kg, respectively (Fig.3). The 
antinociceptive effect of  fentanyl in mice was 
much potent than that induced by morphine. 
These findings are consistent with the expe-
riences in the clinic.  
The opioid analgesic morphine is widely 
used to control pain in cancer patients. 
However, morphine induces severe constipa-
tion. Opioids can delay gastric emptying, 
decrease peristalsis, and slow bowel motility. In 
the present study, we also confirmed the 
gastrointestinal transit inhibition induced by 
morphine in mice. Morphine (0.3, 0.56, 1.7 and 
3 mg/kg, s.c) or fentanyl (17, 30, 56 and 100 
µg/kg,..s.c.) produced dose-dependent inhibi-
tion on gastrointestinal transit in mice. Either 
morphine (3 mg/kg, s.c.) or fentanyl (100 
µg/kg, s.c.) produced the maximal inhibition 
(100 %). The ED50 values for the 
gastrointestinal transit inhibition induced by 
morphine or fentanyl were 0.60 (0.05-1.60) 
mg/kg, s.c. and 32.71 (19.21-52.04) µg/kg, s.c., 
respectively (Fig.3). Morphine with lower doses 
than antinociceptive doses, produced a 
significant increase in gastrointestinal transit 
Fig..1  Antinociceptive effect of  morphine (A) or fentanyl (B) following s.c. administration in the ferret 
using Randall-Selitto test. Antinociception was expressed as a percentage of  maximum possible 
effect (% Antinociception). Each point represents the mean + S.E.M. of  4-6 ferrets. *p<0.05, 
**p<0.01, ***p<0.001 vs. saline group 
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inhibition. However, fentanyl produced no 
gastrointestinal transit inhibition unlike 
morphine. The ED50 value for gastrointestinal 
transit inhibition and ED50 value for anti-
nociception induced by fentanyl was equi-
valence (Fig. 3). However, the ED50 value for 
gastrointestinal transit inhibition induced by 
morphine was approximately 3.5 times lower 
than ED50 value for antinociception by 
morphine (Fig.3). Other preclinical study can 
support these data with the low incidence of  
gastrointestinal adverse effects observed with 
transdermal fentanyl compared with orally 
administered morphine (Megens et al., 1998). 
Inhibition of  gastrointestinal transit of  
systemic opioids on gastrointestinal function is 
mediated by µ-opioid receptors located in the 
central nervous system (CNS) as well as by 
peripheral µ-opioid receptors. The peripheral 
component of  the gastrointestinal transit 
inhibition induced by opioid agonists depends 
on the interaction of  these agonists mainly at 
the µ-opioid receptor. The different effect on 
the gastrointestinal transit inhibition induced by 
fentanyl and morphine may results from the 
lipid solubility and CNS penetration rate of  
fentanyl and morphine (Megens et al., 1998). 
These findings are consistent with the clinical 
experiences in the use of  fentanyl. The clinical 
studies in chronic cancer pain showed that 
transdermal therapeutic delivery system for 
fentanyl (TTS-fentanyl) produces less side 
effects such as constipation, nausea and 
vomiting than that induced by oral morphine 
Fig. 2 Dose-response lines of  antino-ciception 
induced by morphine (s.c.) or fentanyl 
(s.c.) in ferrets using Randall-Selitto test. 
Antinociception was expressed as a 
percentage of  maximum possible effect 
(% Antinociception).  
 
Fig. 3  Dose-response lines of  antinociception and gastrointestinal transit (GIT) inhibition induced by 
morphine (A) or fentanyl (B) in mice. Each point represents the mean + S.E.M. of  5-10 mice. 
Charcoal was administered (p.o.) 20 min or 5 min after morphine (s.c.) or fentanyl (s.c.) injection, 
respectively. Gastrointestinal transit was evaluated 20 min after p.o. administration of  charcoal. 
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(Ahmedzai and Brooks., 1997; Donner and 
Zenz., 1995; Donner et al., 1996; Radbruch et 
al., 2000).  
 
The emetic response after subcutaneous 
injection of morphine or fentanyl in the 
ferrets 
Nausea and vomiting are the most 
distressing adverse effects associated with the 
use of  opioids in cancer patients. Quality of  life 
has shown to be significantly reduced in 
patients who experience opioid-induced nausea 
and vomiting. Based on the clinical experiences, 
we investigated the emetic response induced by 
opioids in ferrets. Morphine (0.1, 0.3, 0.6, 1.2 
and 3 mg/kg, s.c.) induced either the number 
of  retching or vomiting and showed the bell-
shaped curve for the expression of  retching 
and vomiting in the ferrets, whereas fentanyl (1, 
3, 10, 30 and 56 mg/kg, s.c.) failed to induce 
either the number of  retching or vomiting in 
the ferrets (Fig.4). The optimal dose of  
retching and vomiting response induced by 
morphine were achieved at 0.6 mg/kg, s.c. 
(Fig.4). The number of  retching and vomiting 
was decreased at 1.2 mg/kg (s.c.) of  morphine 
and completely abolished at 3 mg/kg (s.c.) of  
morphine. The onset time and duration time of  
vomiting or retching induced by morphine were 
achieved with the maximal emetic response at 
0.6 mg/kg (s.c.) (Fig.5). This effect was 
abolished 15 min after the injection (Fig.6). The 
present study demonstrated that morphine with 
Fig. 4  The emetic response (vomiting and retching) after morphine (A, B) or fentanyl (C, D) by 
subcutaneous (s.c.) injection. Each column represents the mean number of  vomits or retches ± 
S.E.M. of  4-6 ferrets. Animals were observed for 30 min after s.c. morphine or fentanyl injection. 
The fractions represent the number of  animals that showed vomits and retches over the number of  
animals tested in that group. 
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lower doses than that used for antinociceptive 
assay produced either in the number of  
retching or vomiting. However, fentanyl failed 
to produce emetic response in ferrets. These 
findings indicate that fentanyl produces much 
less emesis than that induced by morphine.  
The bell-shaped curve for emesis was 
consistent with previous reports of  morphine 
in ferrets (Barnes et al., 1991; Thomson et al., 
1992; Marrow et al., 1998). In the present study, 
morphine produced a rapid onset and short 
duration of  emetic response. The maximal 
effect of  emetic response induced by morphine 
was approximately achieved at 6-8 min after 
injection. The maximal effect of  emetic 
response induced by morphine was different 
with the antinociceptive effect that was 
achieved at 30 min after injection. This finding 
indicates the different mechanism and site of  
action between emesis and antinociception. In 
the clinical experiences, fentanyl could produce 
nausea and vomiting, whereas we demonstrated 
here that fentanyl failed to produce retching or 
vomiting in ferrets. The discrepancy may result 
from the different physiology or metabolism 
between ferret and human. Other possibility is 
the different situation that fentanyl has been 
used for cancer patients suffering from severe 
pain in the clinic. Patients are also received with 
chemotherapy as an anticancer drugs and 
radiotherapy. Both treatments also induce 
nausea and vomiting in the clinic (Marrow et al., 
1998; Oettle and Riess., 2001; Anonym, 1999). 
 
Fig. 5  The onset time (A) and duration time (B) of  retching and vomiting after morphine injection (s.c.) in 
ferrets. Each column represents the mean number of  vomits and retches ± S.E.M. of  4-6 ferrets. 
Animals were observed for 30 min after s.c. injection of  morphine. The fractions represent the 
number of  animals that showed vomits and retches over the number of  animals tested in that group. 
 
Fig. 6  Time-course of  vomits (A) or retches (B) induced by morphine (0.6 mg/kg, s.c) in the ferrets. Each 
column represents the mean number of  vomits (A) or retches (B) in 2 min interval time ± S.E.M. of  
4-6 ferrets. Animals were observed for 30 min after s.c. injection of  morphine. 
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Conclusion 
Finally, we conclude that fentanyl 
produced potent antinociception in ferrets. In 
addition, fentanyl produced much less side 
effects including emesis and constipation. 
These findings may provide evidence for 
benefit and usefulness of  fentanyl for clinical 
frame on the management of  pain treatment. 
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